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A limited set of T cell receptor (TCR) variable (V) gene
segments are used to create a repertoire of TCRs
that recognize all major histocompatibility complex
(MHC) ligands within a species. How individual
abTCRs are constructed to specifically recognize
a limited set of MHC ligands is unclear. Here we
have identified a role for the differential pairing of
particular V gene segments in creating TCRs that
recognized MHC class II ligands exclusively, or
cross-reacted with classical and nonclassical MHC
class I ligands. Biophysical and structural experi-
ments indicated that TCR specificity for MHC ligands
is not driven by germline-encoded pairwise interac-
tions. Rather, identical TCRb chains can have altered
peptide-MHC (pMHC) binding modes when paired
with different TCRa chains. The ability of TCR chain
pairing to modify how V region residues interact
with pMHC helps to explain how the same V genes
are used to create TCRs specific for unique MHC
ligands.
INTRODUCTION
T cell antigen receptors (TCR) recognize ligands displayed on
classical major histocompatibility complex (MHC), nonclassical
MHC, and MHC-like proteins. Classical MHC proteins are the
most polymorphic genes in humans (Robinson et al., 2009).
Within a population, MHC allele diversity greatly limits the ability
of pathogens to escape immune responses (Kosmrlj et al., 2010;
Messaoudi et al., 2002). However, the diversity of MHC creates
a unique problem for generating host-MHC-restricted mature
T cell repertoires. Prior to selection, TCR rearrangement has to
generate a collection of TCRs that, in aggregate, have the ability
to recognize any of the possibleMHC classes and alleles present
within a species. After selection, individual TCRs must be MHC
class specific, allowing a division of labor between MHC class
II-reactive helper T cells and MHC class I-reactive cytotoxic
T cells (Babbitt et al., 1985; Zinkernagel and Doherty, 1974).694 Immunity 35, 694–704, November 23, 2011 ª2011 Elsevier Inc.The ability to create TCR repertoires specific for ligands pre-
sented by all classes and alleles of MHC requires the generation
of individual receptors with a spectrum of MHC ligand binding
modes. Remarkably, abTCRs accomplish this by using V gene
segmentswith limiteddiversitywithin the complementarity deter-
mining region-1 (CDR1) and CDR2 loops, the portions of the TCR
that primarily contact the MHC (Davis and Bjorkman, 1988). The
majority of TCR diversity occurs within the V(D)J junctional
region of the CDR3 loops that sit atop the bound peptide ligand
(Rudolph et al., 2006). Thymocytes that express these randomly
generated TCRs are prone to react with cells expressing pMHC
ligands (Merkenschlager et al., 1997; Zerrahn et al., 1997). To
mature, preselection thymocytes expressing these TCRs are
subjected to the selective pressures of positive selection to
ensure that T cells are MHC restricted and negative selection to
limit autoimmunity (Fink and Bevan, 1995; Kappler et al., 1987;
Kisielow and von Boehmer, 1995; Mathis and Benoist, 2004).
To account for the high frequency at which self-pMHC-reac-
tive TCRs are created, it has been hypothesized that TCRs and
MHCs have coevolved to bind one another (Jerne, 1971). The
coevolution of TCRs and MHC could involve the overall shape
complementarity of TCRs and MHC, the selection for specific
pairwise contacts between V gene residues and MHC (interac-
tion codons), or the selection of amino acids at the tips of CDR
loops (such a tyrosine) that canmake a variety of chemical bonds
(Al-Lazikani et al., 2000; Garcia et al., 2009; Housset and Malis-
sen, 2003; Marrack et al., 2008). Coevolution models, however,
have to account for several facets of ligand recognition. Both
MHC class I- and MHC class II-specific TCRs are created from
all TCR V gene families and from individual TCR rearrangements
(Garman et al., 1986; Jorgensen et al., 1992). Thus, the identical
TCRa or TCRb residues are capable of binding structurally
somewhat dissimilar and extremely polymorphic MHC class I
and MHC class II proteins. In addition, crystallographic and
biophysical studies show that TCRs use a variety of semicon-
served diagonal docking modes to bind MHC. The only strict
‘‘rules of engagement’’ so far identified are the overall orientation
of TCR binding pMHC and the requirement of the CDR3 loop(s)
to contact the MHC-bound antigen (Housset and Malissen,
2003; Rudolph et al., 2006).
To decipher why self-reactive TCRs are created at a high
frequency, we began studying T cells that develop in mice with
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Development of MHC Class Specificitylimited negative selection. We isolated T cells that recognize the
MHC class II molecule IAb presenting the 3K peptide (IAb-3K).
Many of these T cells are self-reactive, requiring only a few resi-
dues of the peptide for recognition, and primarily engage either
the MHC class II a chain or the MHC class II b chain (Dai et al.,
2008; Huseby et al., 2005, 2006). These pMHC reactivity
patterns are highly analogous to some self-reactive TCRs, iso-
lated from patients with multiple sclerosis and its mouse model,
experimental autoimmune encephalomyelitis (EAE), which utilize
‘‘unconventional’’ binding modes (Wucherpfennig et al., 2009).
Additionally, many of the IAb-3K-reactive TCRs expressed on
the T cells that develop when negative selection is limited are
highly allo-MHC class II reactive, and two were shown to
cross-react with classical MHC class I ligands (Huseby et al.,
2005). In contrast, IAb-3K-reactive TCRs isolated from conven-
tional, C57BL/6 mice are self-tolerant, dependent upon multiple
residues of the peptide and had a standard rate of allo-MHC
class II reactivity. The self-reactive, pMHC-cross-reactive
T cells and the self-tolerant, pMHC-specific TCRs all used
Vb8.1, Vb8.2, and Vb14 TCR chains paired with a diverse array
of TCR Va chains. The construction of TCRs with different
pMHC specificities and pMHC cross-reactivity patterns from
the same V gene segments strongly suggests that control mech-
anisms must exist to modify how germline TCR residues engage
MHC proteins.
To identify mechanisms that control TCR ligand specificity, we
isolated and characterized a set of TCRs reactive to IAb-3K
carrying the identical TCRb chain. The TCRs were either self-
tolerant or self-reactive and differed in the ability to cross-react
with other classes of MHC ligands. By comparing how each
receptor bound the same pMHC complex, we sought to identify
how TCR chain-pairing affects MHC specificity. X-ray crystallo-
graphic and biophysical experiments indicated that MHC-
specific TCRs and MHC class-cross-reactive TCRs utilize
a spectrum of pMHC binding modes within a conventional
docking footprint. Our data demonstrate that differential TCRa
chain pairing can result in MHC-specific TCRs that have altered
TCRb CDR loop conformations and placements, as well as
modified TCRb-MHC contacts.
RESULTS
Identification of IAb-3K-Reactive T Cells with Different
pMHC Specificities
Why randomly created TCRs are prone to being self-reactive and
how this pre-bias is shaped into a foreign-antigen-specific, self-
tolerant T cell repertoire remains unclear. We created a model to
identify mechanisms that control TCR specificity by generating
mice expressing the Vb8.2 TCRb chain of the IAb-3K-reactive
YAe62 TCR as a transgene (YAe62 b mice). YAe62 b mice allow
for the isolation of IAb-3K-reactive TCRs carrying the identical
TCRb chain sequence that develop in either conventional mice
and are dependent upon MHC class II proteins for positive
selection (defined here as MHC specific) or develop in MHC
class II-deficient mice and are dependent upon MHC class I or
nonclassical MHC class I ligands for positive selection (defined
here as MHC cross-reactive). By comparing how these TCRs
engage pMHC, we sought to identify how abTCR chain pairing
controls ligand specificity.IYAe62 b mice are biased toward creating TCRs reactive to
IAb-3K and the related ligand IAb-P-1K. These results were ex-
pected, because the T cell repertoire in mice containing a trans-
genic TCRb chain are often biased toward the antigen specificity
of the parent TCR (Dillon et al., 1994; Jorgensen et al., 1992). To
identify conventional, MHC-specific T cells, YAe62 b mice were
bred onto a MHCwt genetic background. In MHCwt YAe62
b mice, T cells expressing IAb-3K- and P-1K-reactive TCRs
were exclusively in the CD4+ subset of the spleen (Figures
1A–1F). To identify MHC-cross-reactive T cells, YAe62 b mice
were bred onto MHC class II-deficient mice (H2-Ab1/,
Cd74/). A high frequency of CD4+ and CD8+ T cells reactive
to IAb-3K and IAb-P-1K ligand developed in MHC class II-defi-
cient YAe62 b mice as well. A severe reduction in IAb-3K- and
P-1K-reactive T cells was observed in MHCnull (B2m/, H2-
Ab1/,Cd74/) YAe62 bmice, indicating that the development
of these T cells in MHC class II-deficient mice requires b2M-
dependent MHC or MHC-like ligand for selection. Thus, the
IAb-3K- and P-1K-reactive T cells that develop in MHC class
II-deficient mice are reactive to multiple classes of MHC; MHC
class II as they react with IAb tetramers and a selecting b2M-
dependent classical, nonclassical, or MHC-like ligand. Experi-
ments indicate that some IAb-3K-reactive, MHC-cross-reactive
TCRs can cross-react with H2-Kb ligands (Huseby et al., 2005;
Yin et al., 2011), whereas others cross-react with the nonclas-
sical, MHC-like ligand CD1d (see below). Both IAb-3K- and
P-1K-reactive T cells were studied because they express semi-
overlapping T cell repertoires in MHCwt and MHC class II-defi-
cient mice, both of which the YAe62 b mice are biased to
recognize. All of the mice used in this study were heterozygous
for the TCR Ca gene to eliminate the possibility that mature
T cells coexpress two different TCRs.
To ensure that the MHC-specific and MHC-cross-reactive
T cell populations functioned normally, YAe62 bmice were chal-
lenged to make an IAb-3K and P-1K T cell response (Figures
1G–1L). Mice were immunized with a vaccinia virus expressing
the peptide epitope 3K, or P-1K, fused to the carboxyl termini
of IAbb (Vac:IAb-3K, Vac:IAb-P-1K). Because the MHC class
II-deficient mice used in this study are deficient only in IAbb,
the virally expressed IAbb-3K protein pairs with the endogenous
IAba chain, resulting in the cell surface expression of IAb-3K on
infected cells. The expansion of IAb-3K- and P-1K-reactive
T cells in mice on each MHC background indicated the MHC-
specific and MHC-cross-reactive T cells were functional. The
generation of IAb-3K-reactive T cell responses in MHC class
II-deficient mice was independent of TCRb transgene expres-
sion, as shown by the fact that non-TCRb Tg MHC class
II-deficient mice mounted a strong IAb-3K-specific CD4+ and
CD8+ T cell response after Vac:IAb-3K infection (see Figures
S1A–S1F available online).
Germline-Encoded TCR Sequences and Thymic
Selection Impact MHC Specificity
If TCR ligand specificity is strictly created by CDR3 rearrange-
ment, then Va genes should not segregate to either the MHC-
specific or MHC-cross-reactive T cell populations. Strikingly,
we observed that TCR Va gene family usage is a precise indi-
cator of whether YAe62 b+ TCRs are MHC specific or MHC
cross-reactive. IAb-3K- and P-1K-reactive CD4+ T cells inMHCwtmmunity 35, 694–704, November 23, 2011 ª2011 Elsevier Inc. 695
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Figure 1. Development, Expansion, and TCR Va
Gene Family Segregation of MHC-Specific and
MHC-Cross-Reactive T Cells in YAe62 b Mice
(A–F) Spleens from MHCwt (A, D), MHC class II-deficient
(B, E), and MHCnull (C, F) YAe62 b mice were stained with
IAb-3K (A–C) or IAb-P-1K (D–F) tetramers and for the
expression of CD4, CD8, TCRb. Each of the three vertical
panels show CD4+ versus CD8+ staining for splenocytes
on the indicated MHC background followed by the IAb-3K
or IAb-P-1K tetramer expression on the CD4+ or CD8+
T cells. Data are representative of five independent
experiments.
(G–L) MHCwt, MHC class II-deficient, or MHCnull YAe62
b mice were infected with Vac:IAb-3K (G–I) or Vac:IAb-P-
1K (J–L) and the CD4+ T cells (top) and CD8+ T cells
(bottom) from infectedmice were analyzed for the ability to
be stained with IAb-3K or IAb-P-1K tetramer. Data are
representative of five to eight mice per group.
(M–R) MHCwt, MHC class II-deficient, and MHCnull YAe62
bmice were infected with Vac:IAb-3K (M–O) or Vac:IAb-P-
1K (P–R), and the expanded IAb-3K and IAb-P-1K
tetramer-positive, CD4+ T cells were analyzed for Va family
usage. Va2+ IAb-3K- and IAb-P-1K-reactive T cells (top)
are enriched in MHCwt mice and absent in MHC class
II-deficient mice. Va11+ IAb-3K and IAb-P-1K T cells
(bottom) are enriched in MHC class II-deficient mice and
absent in MHCwt and MHCnull mice. Data are representa-
tive of five independent experiments.
Abbreviation: MHC CL2null, MHC class II-deficient. See
also Figure S1.
Immunity
Development of MHC Class SpecificityYAe62 bmice primarily expressed TCRs containing the Va2 gene
segment (Figures 1M–1R; Table S1). These Va2+ T cells were
absent inMHCclass II-deficientmice, indicating that they require
IAb to undergo positive selection. IAb-3K- and P-1K-reactive
CD4+ T cells in MHC class II-deficient YAe62 b mice, however,
often contain a Va11+ gene segment. These Va11+ T cells were
absent in both MHCwt mice and in MHCnull mice. Their absence
in MHCwt YAe62 b mice strongly suggests they are subject
to MHC class II-mediated negative selection, whereas their
absence in MHCnull YAe62 b mice indicates that these T cells
require a b2M-dependent ligand for positive selection.
Consistent with these interpretations, these Va11+ T cells were
eliminated in chimericmice that exclusively expressMHCclass II
on bone marrow-derived cells (Figures S1G–S1J). Furthermore,696 Immunity 35, 694–704, November 23, 2011 ª2011 Elsevier Inc.IAb-3K- and P-1K-reactive Va11+ and Va5+
T cell hybridomas generated from MHC class
II-deficient YAe62 b mice were self-reactive,
whereas Va2+ T cell hybridomas were self-
tolerant. In addition, several of the Va11+ TCRs
were found to be reactive, albeit with weak
affinity, with b2M-dependent, nonclassical
MHC CD1d ligands (Figures 2A–2H and S2).
IAb-3K-reactive CD8+ T cells in MHC class
II-deficient mice (including the parent YAe62
TCR) often use a Va4+ and not a Va2+ TCR
and are cross-reactive with several classical
MHC class I ligands (Huseby et al., 2005).
Thus, TCR Va gene family segregation suggests
that the generation of MHC-specific TCRs can
require specific germline-encoded TCR resi-dues. Similar to our previous studies, TCR specificity is not
dependent upon affinity as shown by the fact that MHC-cross-
reactive TCRs recognizing IAb and CD1d or IAb and H2-Kb
have equilibrium affinities for IAb-3K that overlap with MHC-
specific TCRs (Figures 2I–2L; Figure S2; Table S2).
TCRa Pairing Can Modify How TCRb Chains Bind pMHC
The segregation of IAb-3K-reactive MHC-specific and MHC-
cross-reactive T cells in YAe62 b mice based on TCR Va gene
usage suggested that germline-encoded TCRa residues are
directly contributing to MHC specificity. Thus, it was possible
that the observed Va2 bias in the MHC-specific repertoire
stemmed from the creation of additional interactions between
CDR1a and CDR2a loops with IAb. To identify the side chain
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Figure 2. MHC-Cross-Reactive TCRs Are
Self-Reactive and Have Different MHC
Cross-Reactivities, yet Have Overlapping
TCR-pMHC Equilibrium Affinities with
MHC-Specific TCRs
(A–D) The IAb-3K-reactive T cell hybridomas (A)
YAe62, (B) 4.A5 (isolated from an MHC class
II-deficient mouse), and (C) J809.B5 (isolated from
an MHCwt mouse) and the (D) IAb-P-1K-reactive
T cell hybridoma J210.A3 (isolated from an MHCwt
mouse) were stimulated with either antigen-pre-
senting cells (APC) expressing no MHC, IAb-pre-
senting 3K or P-1K, or IAb-presenting endogenous
self peptides. Data are average of triplicate wells
and are representative of two experiments.
(E–H) The YAe62 (E), 4.A5 (F), J809.B5 (G), or
J210.A3 (H) TCRs were expressed on the surface
in SF9 cells and stained with IAb-3K or IAb-P-1K
tetramer and CD1d-PBS57 tetramer. Shaded
histogram is a negative control tetramer. Data
are representative example of three independent
experiments.
(I–L) Soluble YAe62 (I), 4.A5 (J), J809.B5 (K), or
J210.A3 (L) TCRs were analyzed for equilibrium
binding to immobilized IAb-3K or IAb-P-1K via
SPR. Sensograms are representative of two
independent analyses.
See also Figure S2 and Table S1.
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Development of MHC Class Specificityresidues important for MHC-specific TCRs and MHC-cross-
reactive TCRs to bind IAb-3K, alanine scanning mutagenesis
via surface plasmon resonance (SPR) and a TCR multimer stain-
ing assay was performed (Figure 3; Table S3; Cunningham and
Wells, 1989; Govern et al., 2010; Huseby et al., 2006). Similar
results were obtained with both methods. By comparing the
change in binding affinity (DDG) when a residue is substituted
to alanine, the binding affinity contributed by each residue side
chain can be calculated.
Both MHC-specific TCRs andMHC-cross-reactive TCRs bind
IAb with a conventional footprint. This is visualized in Figures 3
and S3 by color-coding IAb-3K residue side chains according
to the amount of binding energy contributed to TCR binding.
Surprisingly, there is an overall lack in requirements for IAbb
side chain residues, the portion of the MHC that is primarily
contacted by the TCRa chain. These data strongly suggest
that Va2 residues are not creating specificity through additional
contacts with the MHC. The only IAbb side chain required for
high-affinity binding for all of the TCRs is R70. For the IAba resi-
dues, primarily contacted by the TCRb chain, all TCRs relied on
IAba residues K39, L60, N62, and V65 for at least medium-affinity
binding (>0.8 kcal/mol), whereas none of the TCRs require V72
nor K75. Consistent with observations from previous studies
(Huseby et al., 2006), MHC-specific TCRs on average rely
more on peptide andMHC residue side chains for strong binding
(>1.5 kcal/mol) than doMHC-cross-reactive TCRs (Figures 3 and
S3; Table S3). The increase in peptide dependence is similarly
observed in polyclonal T cell responses isolated from MHCwt
versus MHC class II-deficient mice (Figure S3).IMHC-specific Va2+ TCRs were observed to use energeti-
cally unique binding modes at likely TCRb-MHC contacts,
whereas MHC-cross-reactive TCRs used energetically similar
TCRb-MHC binding modes (Figures 4 and S4). The TCR Vb8.2
chain within the parent YAe62 TCR primarily contacts the IAba
chain at aK39, aQ57, and aQ61 with the TCR CDR2b residues
Y46, Y48, and E54, along with CDR3b residue W95 contacting
aQ61 (Dai et al., 2008; Huseby et al., 2005, 2006). Because all
of the TCRs investigated here carry the same TCR Vb chain,
changes in binding affinity (DDG) at TCR Vb-pMHC contacts
can be solely ascribed to modifications induced by differential
TCRa chain pairing. Each of the MHC-specific Va2+ TCRs had
differential requirements for the IAb aQ57 or aQ61 side chains
relative to the parent YAe62 TCR (Figure 4). The TCRb residues
Y46, Y48, and E54 were often required for both MHC-specific
and -cross-reactive TCRs to bind IAb-3K. Thus, the generation
of TCRs containing the Va2 gene segment results in receptors
that have modified how the identical TCR Vb gene residues
bind pMHC.
Structural Comparison of an MHC-Specific
and an MHC-Cross-Reactive TCR
To identify in detail how paring a Va2 TCRa chain with the YAe62
b chain creates pMHC specificity, we determined the 2.7 A˚
crystal structure of the J809.B5 TCR bound to IAb-3K and
compared it to the 3.2 A˚ structure of the YAe62 TCR bound to
IAb-3K (Table S4; Dai et al., 2008). The shared use of the identical
Vb chain provides a direct way to evaluate how different Va pair-
ings control ligand specificity. The overall orientation and size ofmmunity 35, 694–704, November 23, 2011 ª2011 Elsevier Inc. 697
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Figure 3. Energetic ‘‘Footprint’’ of MHC-Cross-
Reactive TCRs and MHC-Specific TCRs
(A–E) pMHC side chain contribution for binding relative to
wild-type IAb-3K for the YAe62 TCR (A), 4A5, 4A6 (Va11+
TCRs) (B, C), 4A3, 4B1 (Va5+ TCRs) (D, E) isolated from
MHC class II-deficient YAe62 b mice.
(F–H) pMHC side chain contribution of binding relative to
wild-type IAb-3K for the J809.B5, J809.G3, or J809.H1,
(Va2+ TCRs) isolated from MHCwt YAe62 b mice.
Individual IAb-3K alanine substitutions covering the
potential TCR binding surface were made in the IAba
chain, IAbb chain, and 3K peptide (see Figure S3). DDG >
1.5 kcal/mol are colored red, DDG = 0.7–1.5 kcal/mol
are colored yellow, and DDG < 0.7 kcal/mol are colored
light gray. The peptide residues are outlined in black.
Data are averages of three independent measurements.
See also Figure S3 and Table S3.
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Development of MHC Class Specificitythe interfaces of the two complexes were highly similar (Figures
5A–5E). Additionally, the conformation of the TCR Ca and TCR
Cb domains and the TCR Va and TCR Vb framework regions
superpose closely. The total buried surface area (BSA) for the
J809.B5 complex is approximately 1560 A˚2, comparable to
1410 A˚2 for the parent YAe62 complex. In both cases the
TCRb chain contributes the majority of contacts to IAb-3K,
74% of the total BSA for the J809.B5 TCR, versus 67% for
YAe62 TCR (Figures 5F and 5G). Some conformational differ-
ences were observed for the TCRa subunit, which was expected
because of the alternate TCRa chain usage (Figure 6). Thus, as
was observed with the energetic footprint analysis (Figure 3),
the J809.B5 TCR does not create self-tolerance from gross
structural alterations.
Alternative TCRa to pMHC contacts by the J809.B5 TCR
versus the YAe62 TCR explains the change in peptide recogni-
tion of J809.B5. The majority of the YAe62 TCRa contacts with
IAb-3K involve CDR1a Y29 engaging the IAbb chain residues
T77 and H81 (Figure 6B, blue). This MHC-dominant binding
mode allows the YAe62 TCR to be less sensitive to alanine
substitutions at several residues of the peptide. In contrast, the
J809.B5 TCRa does not make any substantial contacts with
the IAbb chain (Figure 6B, orange), consistent with the energetic
binding data (Figure 3). However, the J809.B5 CDR3a residues
make extensive interactions with the peptide, including salt
bridges and hydrogen bonds to the peptide side chains at
P-1E, P3K, and P5K (Figure 6C, orange), explaining why these
peptide residues contribute 1.1, >2.2, and >2.2 kcal/mol,
respectively, of binding affinity (Table S2).698 Immunity 35, 694–704, November 23, 2011 ª2011 Elsevier Inc.The J809.B5 TCR Binds IAb-3K with
an Altered TCRb-pMHC Binding Mode
Despite having the identical TCRb sequence,
the TCRb chains within the J809.B5 and
YAe62 TCRs bind IAb-3K differently. The
J809.B5 Va2 chain pairing results in the TCRb
binding IAb-3K with a modified CDR3b loop
conformation and a rigid body movement that
rotates the TCRb chain 1–2 A˚ toward the center
of the interface (Figure 6A, compare J809.B5
CDR3b [green] with YAe62 CDR3b [red]). In
conjunction with the modified TCRb-pMHCbinding mode, a set of TCRa to TCRb interchain contacts are
observed between TCR CDR1a, CDR2a, and CDR3a residue
side chains (orange) with the CDR3b loop (green) (Figure 7A).
Most prominent are contacts between CDR1a Y31 and CDR2a
R50 with CDR3 Jb D97 and between CDR3 Ja A96 with CDR3
JbW95, contacts that are not present in theMHC-cross-reactive
YAe62 TCR.
Differential TCRa chain pairing results in TCRs with altered
ligand recognition at key TCRb contacts of the MHC and
peptide. A favorable contact between IAb aQ61 and a cluster
of residues contributed by CDR1b, CDR2b, and CDR3b (Fig-
ure S5) results in a high-affinity interaction for the J809.B5 TCR
(Figure 4). For the YAe62 TCR, this contact is less favorable,
because the YAe62 Va T97 residue (not shown) forces IAb
aQ61 to adopt an alternate rotamer that makes different
contacts with CDR3b (Figure S5). The side chain rotamer
changes at IAb aQ61 and P5K of the peptide allows the
J809.B5 Vb W95 to insert into a pocket created by the P5K,
IAb aQ61, and aN62 residues despite having a different CDR3b
conformation. Overall, the J809.B5 TCR creates pMHC speci-
ficity by increasing the number of CDR3a contacts with peptide
and by using a modified set of TCRb contacts with both the
peptide and MHC.
The J809.B5 TCR and YAe62 TCR structural comparison
demonstrates that one control mechanism that impacts
ligand specificity is the ability to modify how TCR CDR loop
residues bind pMHC. To determine whether additional abTCR
chain pairings result in receptors with an altered contribution
of specific CDR3b residues for binding IAb-3K, we expressed
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Figure 4. TCRaPairings that CreateMHC-Specific TCRsChange the
Binding Energetics of the YAe62 b Chain at IAba Chain Residues
aQ61 and aQ57
(A–D) The YAe62 (A), J809.B5 (B), J809.G3 (C), and J809.H1 (D) TCRs and each
TCR carrying alanine substitutions at bY48, bY46, and bE54 were expressed
on insect cells and stained with IAb-3K tetramer. Data are percent loss of
tetramer binding as compared to the wild-type TCRs. Data for the TCR
substitution mutations are the average of at least three experiments. Error bars
are the standard error of the independent experiments.
(E–H) The DDG of YAe62 (E), J809.B5 (F), J809.G3 (G), and J809.H1 (H) TCRs
binding IAb-3K carrying alanine substitutions at IAb aQ57, aQ61, and aK39.
The DDG values are those measured by SPR (aQ57 to A, aQ61 to A, Table S2)
or calculated from TCR multimer staining (aK39 to A, Figure S3).
See also Figure S4 and Table S2.
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Development of MHC Class SpecificityIAb-3K-reactive TCRs carrying alanine substitutions at the
CDR3b residues D93, F94, and W95 and measured how these
substitutions impacted ligand binding. The parent YAe62 TCR
creates an H-bond between the CDR3b D93 side chain and
the CDR3b backbone at T98 (Figure 7B). The disruption of this
contact eliminates the ability of the YAe62 TCR to bind IAb-3K
(Figure 7D). In contrast, this H-bond is not present in the
J809.B5 TCR because of the CDR3b conformational change
and thus the D93-to-alanine substitution has minimal effect on
binding IAb-3K (Figures 7C and 7D). Analysis of the other TCRs
revealed that all MHC-cross-reactive TCRs required CDR3b
D93 for binding to IAb-3K, whereas this residue was not required
for any MHC-specific TCRs. The MHC-specific TCRs are more
dependent upon CDR3b F94 for binding, whereas the W95
residue is required for all of the TCRs. Taken together, these
results indicate that differential abTCR chain pairings result in
MHC-specific TCRs that have changed how the TCR CDR3b
chain engages IAb-3K.
DISCUSSION
The identical set of TCRV genes are used to create TCRs that are
specific for either classical or nonclassical MHC class I or MHC
class II ligands. Although there are reports of some TCR V genes
being preferentially used in either CD4+ or CD8+ T cell popula-
tions (DerSimonian et al., 1991; Jameson et al., 1990; Sim
et al., 1996), none of the V genes are precluded from creatingIMHC class I- or MHC class II-specific receptors (Garman
et al., 1986; Jorgensen et al., 1992; Valkenburg et al., 2010).
Thus, TCRs are able to utilize a limited set of TCR V gene resi-
dues to create receptors that bind the highly diverse set of
MHC ligands. The dichotomy that individual TCR chains can
be incorporated into receptors that are able to bind a wide range
of polymorphic MHC ligands whereas complete receptors can
specifically engage a limited set of MHC ligands strongly
suggests that abTCR chain pairings limit MHC cross-reactivity.
The isolation of MHC-specific and MHC-cross-reactive, IAb-
3K-reactive TCRs carrying the identical TCRb chain allowed us
to identify mechanisms by which TCRs become MHC specific.
Several mechanisms probably allow abTCR chain pairing to
create receptors that are specific for MHC ligands. These could
include the binding requirements of each TCR chain for the
pMHC, modification of CDR loop conformational structures,
CDR loop positioning, or induced alterations of the TCR or
pMHC complexes that arise during binding (Garcia et al., 2009;
Housset and Malissen, 2003; Krogsgaard and Davis, 2005; Mar-
rack et al., 2008; Rudolph et al., 2006; Turner et al., 2006). Not
surprisingly, the self-tolerant, MHC-specific TCRs carrying the
YAe62 b chain required binding energy to be contributed from
multiple residues of the peptide at likely TCRa contacts.
However, MHC-specific TCRs did not require additional MHC
contacts at potential TCRa binding sites. Within the J809.B5
TCR-pMHC structure, no contacts were observed between the
CDR1a and CDR2a loops with IAb-3K. Our data further demon-
strated that TCRa pairings, which created MHC-specific TCRs,
had a modified TCRb binding reaction with pMHC. Thus, TCRa
chains did not influence pMHC specificity by requiring additional
MHC class- or allele-specific contacts. This was a surprising
observation given the strong Va2 gene segregation to MHC-
specific TCR and suggested that this skewing was not based
on TCR Va gene residues providing contacts with the pMHC.
The phenomena of TCR V gene skewing is well documented in
graft rejection, responses to viruses, autoimmunity, and MHC
restriction (Fink et al., 1986; Urban et al., 1988; Winoto et al.,
1986). Three major TCR V gene skewings are known to occur;
the use of a particular TCR V gene family with diverse CDR3
sequences, the selection for TCRs that carry a particular CDR3
N-D-J sequence motif, and those T cell responses that select
the identical TCRa or TCRb sequence (Turner et al., 2006). The
investigations of the molecular basis of TCR Va skewing have
focused on identifying particular TCR residues that mediate or
stabilize pMHC binding and have found heavily CDR3-depen-
dent binding TCRs, aswell as TCRs that requiremultiple contacts
between germline CDR1 and CDR2 residues with MHC (Borg
et al., 2005; Maynard et al., 2005). Experiments here suggest
an additional role for particular TCR V gene residues in allowing
or restraining MHC cross-reactivity and thus creating MHC
ligand specificity.
The two IAb-3K-reactive TCRs (4.A5 and 4.A6) that cross-react
with CD1d-PBS57 use the identical or near-identical CDR3a
sequence as the Ja50+ noncanonical CD1d-reactive TCR 143.3
(Behar et al., 1999) and a set of Va10+ noncanonical CD1d-
reactive TCRs (Uldrich et al., 2011). The recent structure of
a Va10-Ja50 TCR bound to CD1d indicates that these TCRs bind
CD1d with a relatively similar docking mode as do the canonical
Va14-Ja18 NKT TCRs (Uldrich et al., 2011). This TCR-CD1dmmunity 35, 694–704, November 23, 2011 ª2011 Elsevier Inc. 699
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Figure 5. MHC-Cross-Reactive and MHC-Specific TCRs Bind IAb-3K within a Similar Footprint
(A) Overlay of YAe62 and J809.B5 TCRs binding IAb-3K. The YAe62 TCR is colored red (TCRb) and blue (TCRa); the J809.B5 TCR is colored green (TCRb) and
orange (TCRa). IAb-3K is colored cyan (IAba chain), yellow (peptide), and magenta (IAbb chain).
(B and C) Projection of IAb-3K binding onto the (B) YAe62 TCR or (C) J809.B5 TCR. Contacts with the IAba chain (cyan), peptide (yellow), and the IAbb chain
(magenta). Black line demarcates border of the TCRa subunit from the TCRb subunit.
(D and E) Projection of the YAe62 TCR (D) or J809.B5 TCR (E) binding onto IAb-3K. YAe62 TCRa contacts are colored blue, YAe62 TCRb contacts are colored red.
The J809.B5 TCRa contacts are colored orange and the TCRb contacts are colored green. The peptide residues are outlined in black.
(F and G) The amount of buried surface area (BSA) contributed by the YAe62 (F) or J809.B5 (G) TCRa and TCRb loops to the binding reaction with IAb-3K.
(H and I) The amount of BSA contributed by the peptide or MHC chains for the binding reaction with YAe62 TCR (H) or the J809.B5 TCR (I).
Figures were made with PyMol (DeLano, 2002). See also Figure S5 and Table S4.
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Development of MHC Class Specificitydocking footprint is highly divergent from the docking site of
TCRs on MHC class II proteins. These binding site differences
suggest that the 4.A5 and 4.A6 TCR CDR loops are either suffi-
ciently flexible, like the parent YAe62 TCR, to adopt two distinct
conformations, thereby allowing similar amino acids to bind
different classes ofMHC ligands, or are in the same conformation
and bind MHC class II and CD1d with different strategies (Colf
et al., 2007; Yin et al., 2011). The conservation of the CDR3a
sequences of noncanonical TCRs binding CD1d strongly sug-
gest that the Ja50sequenceof the4.A5and4.A6TCRs is contrib-
uting to the MHC class cross-reactivity. In addition, the strong
bias to express a Va11+ TCR suggests that the germline residues
are also involved in creating reactivity for CD1d and or IAb-3K.700 Immunity 35, 694–704, November 23, 2011 ª2011 Elsevier Inc.In contrast to the Ja50+ MHC-cross-reactive TCRs, the three
MHC-specific Va2+ TCRs studied in detail were generated
from two different Ja family members and had CDR3a lengths
of 12, 13, and 14 amino acids. Surprisingly, the Va2+ TCRs did
not require additional binding affinity to be contributed from
MHC contacts at potential TCRa binding sites. Within the
J809.B5 TCR structure, the CDR1a and CDR2a residues do
not contact the pMHC. Instead, germline-encoded residues of
the Va2 loops along with CDR3a residues make direct contacts
with the TCRb chain. These TCRa to TCRb interchain contacts
may create or stabilize the altered TCR CDR3b conformation.
Thus, germline-encoded TCR V sequences may aid the genera-
tion of pMHC ligand specificity by providing interchain contacts
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Figure 6. The J809.B5 TCRa Chain Induces a TCR Rigid Body Move-
ment and Replaces the YAe62 TCRa Contacts to MHC with TCRa
Contacts to the Peptide
(A) A rigid body movement rotates the J809.B5 TCRb chain 1–2 A˚ toward the
peptide; J809.B5 TCRb (green), J809.B5 TCRa (orange), YAe62 b (red), and
YAe62 a (blue).
(B) The YAe62 CDR1 aY29 (blue) contacts IAb bT77 and bH81 whereas the
J809.B5 CDR1a (orange) makes no contact with the IAbb chain.
(C) The J809.B5 CDR3a (orange) makes extensive contacts with the P-1E and
P3K residues of the peptide whereas the YAe62 CDR3a (blue) makes very few.
Salt bridge (black arrow) and hydrogen bonds (red dashed lines) between
J809.B5 CDR3a and the 3K peptide are shown.
Figures were made with PyMol (DeLano, 2002).
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Development of MHC Class Specificitythat influence the placement or conformations of paired TCR
chain loops.
The pairing of the YAe62 b chain with Va2 TCRa chains,
creating MHC-specific TCRs, resulted in the Vb8.2 portion of
the TCRs to engage IAb-3K with diverse interactions. The
Vb8.2 gene segment contains CDR2b residues Y46, Y48, and
E54, which have been found to make pairwise contacts with
the IA residues a39K, a57Q, and a61Q (Garcia et al., 2009;
Maynard et al., 2005), a proposed ‘‘interaction codon’’ that
guides TCR recognition of pMHC. Most of the TCRs studied
here used all three of the CDR2b residues (Y46, Y48, and E54)
in binding IAb-3K, consistent with the findings that the same V
gene residues are often used to bind pMHC (Burrows et al.,
2010; Rudolph et al., 2006). In addition, the MHC IAba side
chains of the interaction codon, a39K, a57Q, and a61Q, were
not always required by the MHC-specific TCRs to bind IAb-3K.
These observations are inconsistent with the model that MHC
reactivity arises from structurally encoded specific pairwise
contacts between TCRs and MHC (Garcia et al., 2009). Rather,
our data indicate that individual TCR CDR loop residues can
engage pMHC with an array of interactions, which can be influ-
enced by the paired TCR chain. TCR-pMHC binding specificityIwill probably be impacted by allelic variations of TCRa and
TCRb sequences as well (Gras et al., 2010). The variable
requirements for centrally located, often recognized MHC side
chains have been noted for TCR binding to MHC class I as well
(Ding et al., 1998; Rudolph et al., 2006). The highly conserved,
MHC class I residues Q65, T69, and Q155 are invariably con-
tacted by most bound TCRs, yet they also contribute variable
amounts of binding energy for individual TCRs (Burrows et al.,
2010).
How often TCRa to TCRb contacts impact ligand specificity is
unknown. All TCRs make extensive TCRa to TCRb interchain
contacts, which can occur between residues of the two CDR3
loops and between residues of CDR3 and those of CDR1 and
CDR2. Analyses of the few structures of TCRs that carry an iden-
tical TCRa or TCRb sequence support the idea that TCRa to
TCRb interactions can modify how TCRs bind MHC ligands.
Though still specific for the same antigen, the pairing of a Vb7+
versus a Vb8.2+ TCRb chain with the canonical Va14Ja18 NKT
TCRa chain resulted in residues of the CDR3a chain adopting
different rotamers (Pellicci et al., 2009). Localized side chain
rotamer changes at the TCR-pMHC binding site were similarly
observed for a set of human TCRs, the TK3 receptor, and altered
versions carrying TCRbmicropolymorphisms (Gras et al., 2010).
Consistent with the hypothesis that TCR chains can modify the
ligand specificity of the paired chain, TCRs containing a TCRa
chain from the 149.42 TCR-specific H2-Kb + OVA can be incor-
porated into TCRs specific for H2-Db + influenza (Valkenburg
et al., 2010). However, the mechanism that allows the 149.42
TCRa chain to bind an alternate unique ligand is currently
unknown. In addition, molecular modeling experiments suggest
that TCR interchain contacts will contribute to the specificity of
human TCRs reactive to influenza as well (Zhong et al., 2007).
TCRa-induced changes to TCRb were not, however, observed
in the structures of the 2C TCR and the highly similar, high-
affinity variant M6 bound to H2-Ld (Colf et al., 2007). Thus, the
impact of chain pairing on how each TCRa or TCRb chain binds
pMHC ligands can span from no effect all the way to the rigid
body movements and CDR3 conformational changes observed
for the J809.B5 and YAe62 TCRs.
The strength of the interaction of the TCR with MHC ligands
does not appear to regulate MHC specificity, because MHC-
specific and MHC-cross-reactive TCRs had similar equilibrium
affinity for IAb-3K. These data are consistent with our previous
findings indicating that peptide-cross-reactive TCRs and
peptide-specific TCRs have similar equilibrium affinities (Huseby
et al., 2005, 2006). In other systems, cross-reactive pMHC
ligands have been identified for a multitude of different T cells.
The affinities or avidities for the cross-reactive ligands have
been demonstrated to beweak or strong (Krogsgaard andDavis,
2005; Stone et al., 2009). For the MHC class-cross-reactive
ligands described here, the 4.A5 and 4.A6 TCRs have a weak
interaction with the nonclassical MHC class I ligand, CD1d-
PBS57, though it is possible that other bound ligands may facil-
itate stronger affinity interactions with these TCRs (Wun et al.,
2011). In contrast, the YAe62 TCR is strongly alloreactive to
self peptides presented by H-2k MHC class I proteins and
recognizes a H2-Kb ligand with an equilibrium affinity of 15 mM
(Huseby et al., 2005; Yin et al., 2011). These data indicate that
TCR recognition of the cross-reactive MHC ligand does notmmunity 35, 694–704, November 23, 2011 ª2011 Elsevier Inc. 701
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Figure 7. TCRa Chains Can Induce a Confor-
mational Change to the TCRb CDR3 Loop
(A) The J809.B5 CDR3b chain (green) is in an altered
conformation as compared to the identical CDR3b
chain within the YAe62 TCR (red). The J809.B5
CDR3b chain creates a hydrogen bond (red dashed
lines) with J809.B5 CDR1 aY31 and CDR2 aR50 and
a Van der Waals contact (red arrow) with CDR3
JaA96.
(B and C) Within the YAe62 TCR (B), an internal
hydrogen bond is created between CDR3 bD93 and
themain chain of bT98. This internal hydrogen bond is
absent within the J809.B5 TCR (C).
(D) The MHC-cross-reactive and MHC-specific
TCRs and each TCR carrying alanine substitutions
at bD93, bF94, and bW95 were expressed on insect
cells and stained with IAb-3K tetramer. The MHC-
cross-reactive TCRs (red bars) are displayed in
the order: YAe62, 4.A3, 4.B1, 4.A5, and 4.A6. The
MHC-specific TCRs (green bars) are displayed in
the order: J809.B5, J809.G3, and J809.H1. Data are
percent loss of tetramer binding as compared to the
wild-type TCRs. Data for the TCR substitution muta-
tions are the average of at least three experiments.
Error bars are the standard error of the independent
experiments.
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Development of MHC Class Specificityhave an intrinsically strong or weak affinity. TCR-pMHC affinity
certainly dictates the threshold of whether a T cell functionally
engages a cross-reactive ligand; however, our data strongly
suggest that TCR specificity for uniqueMHC ligands is not based
on affinity.
Despite intense research and an increasing number of TCR-
pMHC structures, the reason why TCRs are prone to being
self-reactive and how specificity arises for foreign antigens is
largely lacking in detail. We have demonstrated that differential
TCRa pairing can alter how TCRb chains engage MHCs and
influence the pMHC specificity of the TCR. The ability to
affect TCR-MHC ligand specificity by subtle binding site reorga-
nization and loop conformational changes through differential
chain pairing probably enhances the efficiency of creating
an abTCR repertoire that can bind all the possible MHCs
present within the species while simultaneously providing a
mechanism for limiting the self-reactive and cross-reactive
nature of TCRs.EXPERIMENTAL PROCEDURES
Mice
C57BL/6, b2-microglobulin (b2m/), invariant chain/ (Cd74/), and TCR
Ca/ mice were purchased from The Jackson Laboratory (Bar Harbor, ME).
H-2Ab1/ (MHC class II-deficient) mice were purchased from Taconic
(Germantown, NY). MHCwt: TCR Ca+/ C57BL/6 mice; MHC class II-deficient:
TCR Ca+/, Cd74/ H-2Ab1/, C57BL/6 mice; MHCnull: TCR Ca+/, B2
m/, Cd74/ H-2Ab1/, C57BL/6 mice. Tcrb Tg mice were established
by expressing rearranged PCR-cloned TCRs via the human CD2 promoter
(Zhumabekov et al., 1995). The Tg TCRb chain is expressed on >99% of all
CD4+ and CD8+ T cells. All mice were maintained in a pathogen-free environ-
ment in accordance with institutional guidelines in the Animal Care Facility at
the University of Massachusetts Medical School.702 Immunity 35, 694–704, November 23, 2011 ª2011 Elsevier Inc.Recombinant Vaccinia Viruses and Immunization of Mice
Recombinant vaccinia viruses expressing the peptide epitope 3K or P-1K
fused to the carboxyl termini of full-length IAbb (Vac:IAb-3K or Vac:IAb-P-1K)
were constructed with standard techniques. Mice were infected i.p. with
107 PFU Vac:IAb-3K or Vac:IAb-P-1K. The 3K peptide is FEAQKAKANKAVD,
numbered P2 to P11, the P-1K peptide is FKAQKAKANKAVD.
Calculation of DG and DDG
Free energy of binding (DG) was calculated with the equation:
DG=  R  T  lnK1d

where R is the gas constant 1.987 cal/(mol*K) and T is temperature in degrees
Kelvin. To calculate the amount of binding energy contribution by a parental
side chain, the free energy of the parental side chains was compared to an
alanine substitution at the given position. Thus, the parental side chains’
contribution was determined as:
DDG=DG of alanine substitution  DG of WT side chain:
Crystallization and Data Collection
J809.B5 TCR and IAb-3K proteins were mixed at 10 mg/ml each and crystal-
lized by hanging-drop vapor diffusion at room temperature over 12% PEG
4000, 100 mM sodium citrate, and 100 mM sodium cacodylate, at pH 5.0.
Crystals about 25 mm 3 25 mm 3 100 mm typically formed within a few days.
For data collection, crystals were transferred to crystallization buffer contain-
ing 25% (w/v) glycerol and were flash-cooled by plunging into liquid nitrogen.
X-ray diffraction data were collected from a single crystal at 100K with 1.10 A˚
radiation at the National Synchrotron Source X25 undulator beamline at
Brookhaven National Laboratory. Diffraction data were indexed, integrated,
and scaled with HKL2000 (Otwinowski and Minor, 1997). Unit cell parameters
and data collection statistics are shown (Table S4). See Supplemental
Information for structural determination and analysis.
Nomenclature and Amino Acid Numbering
Vbs and Vas are named and their amino acids numbered according to the
IUIS/Arden compilation (Arden et al., 1995).
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Coordinates and structure factors for the J809.B5 TCR-IAb-3K complex are
available from the Protein Data Bank under accession number 3RDT.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
five figures, and four tables and can be found with this article online at
doi:10.1016/j.immuni.2011.10.012.
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